Investor Video Call // February 25, 2026 // 2:00 p.m. CET
Q4/FY 2025 Results
Top row, from left to right: Bill Anderson, Chairman / Wolfgang Nickl, Finance / Stefan Oelrich, Pharmaceuticals
Lower row, from left to right: Rodrigo Santos, Crop Science / Julio Triana, Consumer Health